Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takeru Matsuda

Showing results (121-130 of 233) with videos related to

Pageof 24
Sort By:
Anticancer Research|December 30, 2023
Alb-dNLR Score as a Novel Prognostic Marker for Patients With Locally Advanced Rectal Cancer Undergoing Neoadjuvant ChemoradiotherapyTakashi Nakanishi, Takeru Matsuda, Kimihiro Yamashita, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 2, 2024
[Significance of Preoperative Adjuvant Therapy and Subsequent Selective Inguinal Lymph Node Dissection for Rectal or Anal Canal Adenocarcinoma with Inguinal Lymph Node Metastases]Takashi Nakanishi, Hiroshi Hasegawa, Ryuichiro Sawada, et al.
Scientific Reports|October 10, 2023
The modified Glasgow prognostic score is a reliable predictor of oncological outcomes in patients with rectal cancer undergoing neoadjuvant chemoradiotherapyAtsushi Shimada, Takeru Matsuda, Ryuichiro Sawada, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2005
Inhibition of p38 pathway suppresses human islet production of pro-inflammatory cytokines and improves islet graft functionTakeru Matsuda, Keiko Omori, Tommy Vuong, et al.
Scientific Reports|June 4, 2025
A randomized controlled trial exploring the effect of placement versus nonplacement of a drainage tube around the cervical anastomosis in McKeown esophagectomyTaro Oshikiri, Hironobu Goto, Takashi Kato, et al.
BJS Open|February 9, 2026
Neoadjuvant FOLFOXIRI plus bevacizumab without radiotherapy for high-risk rectal cancer: multicentre phase II trialTakeru Matsuda, Yoshiaki Nagatani, Yohei Funakoshi, et al.
Annals of Surgical Oncology|October 8, 2017
The Surgical Apgar Score Predicts Not Only Short-Term Complications But Also Long-Term Prognosis After EsophagectomyAkio Nakagawa, Tetsu Nakamura, Taro Oshikiri, et al.
Langenbeck'S Archives of Surgery|March 25, 2018
Standardizing procedures improves and homogenizes short-term outcomes after minimally invasive esophagectomyTaro Oshikiri, Tetsu Nakamura, Hiroshi Hasegawa, et al.
BMC Gastroenterology|December 4, 2020
Severe weight loss after minimally invasive oesophagectomy is associated with poor survival in patients with oesophageal cancer at 5 yearsYasufumi Koterazawa, Taro Oshikiri, Gosuke Takiguchi, et al.
Surgical Innovation|February 14, 2023
Evaluation of the Efficiency of a Joystick-Guided Robotic Scope Holder Compared to That of Human Scopists: A Prospective TrialTakuya Kudo, Shingo Kanaji, Hitoshi Harada, et al.
Pageof 24

Showing results (121-130 of 233) with videos related to

Sort By:
Pageof 24
Anticancer Research|December 30, 2023
Alb-dNLR Score as a Novel Prognostic Marker for Patients With Locally Advanced Rectal Cancer Undergoing Neoadjuvant ChemoradiotherapyTakashi Nakanishi, Takeru Matsuda, Kimihiro Yamashita, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 2, 2024
[Significance of Preoperative Adjuvant Therapy and Subsequent Selective Inguinal Lymph Node Dissection for Rectal or Anal Canal Adenocarcinoma with Inguinal Lymph Node Metastases]Takashi Nakanishi, Hiroshi Hasegawa, Ryuichiro Sawada, et al.
Scientific Reports|October 10, 2023
The modified Glasgow prognostic score is a reliable predictor of oncological outcomes in patients with rectal cancer undergoing neoadjuvant chemoradiotherapyAtsushi Shimada, Takeru Matsuda, Ryuichiro Sawada, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 15, 2005
Inhibition of p38 pathway suppresses human islet production of pro-inflammatory cytokines and improves islet graft functionTakeru Matsuda, Keiko Omori, Tommy Vuong, et al.
Scientific Reports|June 4, 2025
A randomized controlled trial exploring the effect of placement versus nonplacement of a drainage tube around the cervical anastomosis in McKeown esophagectomyTaro Oshikiri, Hironobu Goto, Takashi Kato, et al.
BJS Open|February 9, 2026
Neoadjuvant FOLFOXIRI plus bevacizumab without radiotherapy for high-risk rectal cancer: multicentre phase II trialTakeru Matsuda, Yoshiaki Nagatani, Yohei Funakoshi, et al.
Annals of Surgical Oncology|October 8, 2017
The Surgical Apgar Score Predicts Not Only Short-Term Complications But Also Long-Term Prognosis After EsophagectomyAkio Nakagawa, Tetsu Nakamura, Taro Oshikiri, et al.
Langenbeck'S Archives of Surgery|March 25, 2018
Standardizing procedures improves and homogenizes short-term outcomes after minimally invasive esophagectomyTaro Oshikiri, Tetsu Nakamura, Hiroshi Hasegawa, et al.
BMC Gastroenterology|December 4, 2020
Severe weight loss after minimally invasive oesophagectomy is associated with poor survival in patients with oesophageal cancer at 5 yearsYasufumi Koterazawa, Taro Oshikiri, Gosuke Takiguchi, et al.
Surgical Innovation|February 14, 2023
Evaluation of the Efficiency of a Joystick-Guided Robotic Scope Holder Compared to That of Human Scopists: A Prospective TrialTakuya Kudo, Shingo Kanaji, Hitoshi Harada, et al.
Pageof 24